Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
For all of President Donald Trump’s showmanship, the share of Americans his policies will likely help remains slim, even if some patients do come out ahead.
Showing 1 - 20 of 111
-
-
As ICE Moved In, Minnesotans Set Up a Shadow Medical System. It’s a Lesson for Other Cities.
President Donald Trump’s immigration crackdown in Minneapolis forced families into hiding and catalyzed informal medical networks to deliver critical health care services.
By Arthur Allen and Kate Wells -
Vaccines Jettisoned by CDC Safeguarded Millions From Disease
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Arthur Allen and Jackie Fortiér -
The CDC Just Sidelined These Childhood Vaccines. Here’s What They Prevent.
The CDC is recommending fewer childhood vaccines, although the ones it has jettisoned from the recommended schedule have successfully battled serious illness for years. Experts warn that if vaccine uptake falls, millions could be hospitalized — or worse — as a result of preventable diseases.
By Arthur Allen and Jackie Fortiér -
In RFK Jr.’s Upside-Down World of Vaccines, Panel Votes To End Hepatitis B Shot at Birth
A session of a vaccine panel dominated by skeptics was chaotically at odds with past practices of the CDC, which HHS Secretary Robert F. Kennedy Jr. has described as a “cesspool of corruption.” His crew voted to end a 34-year recommendation to vaccinate newborns against hepatitis B.
By Arthur Allen -
What To Know About the CDC’s Baseless New Guidance on Autism
A reshaped CDC website suggesting that vaccines cause autism has appalled the medical community.
By Arthur Allen -
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
By Arthur Allen -
At The Hollow in Florida, the ‘Medical Freedom’ Movement Finds Its Base Camp
Florida’s surgeon general, spiritual healers, and Trump allies push their cures in a swampy outpost of anti-government absolutism and mystical belief.
By Arthur Allen -
Doctors Muffled as Florida Moves To End Decades of Childhood Vaccination Mandates
Florida has announced plans to end mandatory vaccination. Now scientists are assessing which of several diseases deadly to children — whooping cough, measles, polio, rubella, mumps, diphtheria, and tetanus — are likely to make a resurgence and when.
By Arthur Allen -
Mercury in Your Hot Dog? Vaccine Skeptics Face Their Limits at Crucial CDC Meeting
A Centers for Disease Control and Prevention meeting on vaccines pitted scientific expertise against vaccine skepticism. An often confusing debate ended with critics of the current vaccine schedule tabling a vote to remove one of its cornerstones.
By Arthur Allen and Renuka Rayasam -
Kennedy’s Take on Vaccine Science Fractures Cohesive National Public Health Strategies
A lack of faith in the soundness of the Centers for Disease Control and Prevention’s new direction has led states to explore enacting their own vaccine policies. A patchwork of divergent recommendations and requirements could result.
-
Watch: Fired CDC Chief Says RFK Jr. Demanded She Roll Back Vaccine Policies Without Evidence
Susan Monarez and former Centers for Disease Control and Prevention chief medical officer Debra Houry described turmoil in an agency dominated by anti-vaccine political officials nominated by Health and Human Services Secretary Robert F. Kennedy Jr.
By Arthur Allen and Hannah Norman -
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
By Arthur Allen -
Changes at NIH Give Political Appointees Greater Power To Fund or Block Research
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
By Arthur Allen -
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
By Arthur Allen -
World’s Premier Cancer Institute Faces Crippling Cuts and Chaos
After spearheading a 34% cut in cancer mortality, the National Cancer Institute at the NIH is bleeding resources and staff and could see its budget cut by nearly 40%.
By Rachana Pradhan and Arthur Allen -
Kennedy’s Vaccine Advisers Sow Doubts as Scientists Protest US Pivot on Shots
A new vaccine advisory panel appointed by the HHS secretary, a longtime anti-vaccine activist, reflected his unsupported claims about the safety of childhood inoculations.
By Arthur Allen and Sam Whitehead -
What RFK Jr. Isn’t Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
By Arthur Allen -
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
By Arthur Allen -
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
By Jackie Fortiér and Arthur Allen
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: